Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bias

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Unrealistic Optimism Bias

Unrealistic Optimism Bias

Unrealistic optimism bias is the tendency to overestimate the likelihood of positive outcomes. This cognitive bias makes individuals believe they are less likely to experience failures, setbacks, or risks and more likely to succeed than others. For example, people may assume they are less prone to health issues, accidents, or financial struggles than their peers, even when they share similar risk factors.One key component of this bias is the above-average effect, where individuals perceive...

iChip

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...

Odds Ratio

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...

Bioreactor Controls-III

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Making the case to managed care: the science of marketing biologics.

Biotechnology healthcare·2013

Same author

Are biotech and consumer-directed healthcare compatible?

Biotechnology healthcare·2013

Same author

Specialty pharmacies tackle top 5 employer concerns.

Biotechnology healthcare·2013

Same author

Payers' costly battle against cancer.

Biotechnology healthcare·2013

Same author

Reimportation and biotech: a germinating crisis?

Biotechnology healthcare·2013

Same author

NYCLIX: New York HIE life. An expansive HIE network has taken shape in the nation's most densely populated urban area.

Healthcare informatics : the business magazine for information and communication systems·2010

Search research articles

Related Experiment Video

Updated: May 14, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Bio bets its chips on better outcomes.

Biotechnology Healthcare

|February 9, 2013

Summary

This summary is machine-generated.

The pharmacogenomics revolution, driven by DNA chips, is enabling personalized medicine. However, equitable access to these advanced genomic technologies remains a critical challenge.

More Related Videos

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

Related Experiment Videos

Last Updated: May 14, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

Area of Science:

Genomics
Biotechnology
Personalized Medicine

Background:

The rapid advancement of DNA chip technology is accelerating the field of pharmacogenomics.
The convergence of Silicon Valley innovation and biotechnology is paving the way for personalized medicine.

Purpose of the Study:

To explore the implications of widespread DNA chip adoption in pharmacogenomics.
To examine the potential of personalized medicine driven by technological advancements.
To address the critical question of equitable access to high-tech genomic tools.

Main Methods:

Review of current trends in DNA chip technology and pharmacogenomics.
Analysis of the intersection between technology, biotechnology, and personalized medicine.
Discussion of access and equity issues related to advanced genomic tools.

Main Results:

DNA chips are rapidly advancing pharmacogenomics, bringing personalized medicine closer to reality.
The integration of technology and biotech is a key driver for personalized medical approaches.
Significant questions remain regarding equitable access to these transformative technologies.

Conclusions:

The pharmacogenomics revolution is imminent, promising tailored medical treatments.
Personalized medicine, enabled by DNA chips, offers significant potential.
Ensuring broad and fair access to these powerful genomic tools is paramount for societal benefit.